Objective. The pathophysiology of fibromyalgia has been related to central pain sensitization. This study tested a laboratory protocol evaluating responses to slowly repeated evoked pain stimuli (SREP) that may index central pain sensitization in fibromyalgia.
Introduction
Fibromyalgia (FM) is a chronic pain condition with a largely unknown etiology. The pathophysiology of FM has been related to the central pain sensitization processes [1] , which can involve both brain and spinal cord mechanisms [1] . For example, neuroimaging techniques have repeatedly shown greater responses in brain regions underlying pain processing in FM [2] [3] [4] . Spinal cord sensitization, defined as an excessive synaptic responsiveness in somatosensory neurons of the dorsal horn of the spinal cord that accompanies a deficit in postsynaptic inhibition, has been also found in FM [5, 6] . Both brain and spinal sensitization mechanisms can lead to increased sensitivity to innocuous (allodynia) and painful (hyperalgesia) stimuli.
Consistent with central pain sensitization, FM patients show lower pain threshold and tolerance values than healthy individuals [7] [8] [9] . One laboratory marker hypothesized to index specifically central sensitization is temporal summation of pain (TSP). TSP is defined as a process of increased pain perception due to the frequency rather than the magnitude of painful stimuli that results from spinal cord summation of second pain [10] . TSP protocols involve repeated pain stimulation and evaluation at high-frequency rates (>0.33 Hz). Increased TSP has been found in FM patients in response to various forms of painful stimulation such as heat and mechanical pressure stimulation [11] [12] [13] [14] .
Informal observations in our laboratory suggested that FM patients reported increased perceived pain intensity in response to repetitive low-intensity pain stimuli with an interstimulus interval of approximately 30 seconds. These observations are congruent with the possibility of evoking central sensitization through repeated evoked pain stimuli in FM patients at frequencies lower than the 0.33 Hz that is assumed to be required to elicit temporal summation [15] . Indeed, prior work by Staud et al. indicates that a pattern of increased perceived pain intensity was observed with repeated stimuli, even with a maximum interstimulus interval of 12.5 seconds (0.08 Hz) under certain conditions [15] . Also supporting this possibility are observations of prolonged aftersensations and slow decay of pain following TSP stimulation [13, 14] , with aftersensations at 15 seconds and 30 seconds following pain stimuli being more predictive of clinical pain intensity than the TSP itself [16] .
All of these findings could suggest the existence of a prolonged facilitation of nociceptive synaptic transmission in dorsal horn neurons in FM. Repeated nociceptive C-fiber stimulation causes increases in neuronal excitability of spinal cord neurons that outlast the stimuli and are often followed by the development of afterdischarge phenomena [17, 18] . Lasting facilitation of synaptic transmission in the dorsal horn neurons is a key factor in the development of central sensitization [19] . Furthermore, increased activity in brain regions underlying pain processing during repeated stimulation (even at lower frequency rates than 0.33 Hz), including structures related to both the affective and cognitive components of pain [2, 3] , may also contribute to central sensitization.
Based on the observations above, the aim of this study was to test a protocol for evaluating pain sensitization in FM patients in response to slowly repeated evoked pain stimuli (SREP) with a much longer interstimulus interval than in past work. The SREP protocol consisted of a single series of nine pressure pain stimuli of five-second duration and low-suprathreshold intensity presented at 30-second intervals. Given this long interstimulus interval, the SREP protocol clearly cannot be considered to be eliciting traditional TSP. The aims of this study were to evaluate the degree of pain sensitization elicited by SREP compared with two of the most common laboratory evoked pain measures, pain threshold and pain tolerance, in terms of 1) associations with ratings of clinical FM pain and 2) sensitivity and specificity in differentiating between FM patients and healthy control participants.
We expected to find that 1) SREP sensitization would be observed in FM patients but not in healthy controls; 2) FM patients would exhibit lower pain threshold-tolerance levels than healthy controls; 3) in FM patients, clinical pain would show stronger associations with SREP sensitization than with threshold-tolerance; 4) SREP sensitization would show greater sensitivity and specificity than would pain threshold-tolerance measures for discriminating between FM and healthy control participants; and 5) associations between pain thresholdtolerance and SREP sensitization would be weak if the SREP protocol tapped into different pain mechanisms.
Methods

Participants
Twenty-four women suffering from FM participated in the study. They were recruited through the Fibromyalgia Association of Jaé n (Spain), and all met the 1990 American College of Rheumatology criteria for FM based on review of medical records from rheumatologists [20] . For comparison, 24 healthy women free of chronic pain were recruited from collaborators of the same association to serve as a healthy control group. Controls were matched to the patients with respect to both age and body mass index to minimize potential confounds. Exclusion criteria for all participants were: any cardiovascular disease, metabolic abnormality, neurological disorder, inflammatory pain, or severe somatic (e.g., cancer) or psychiatric diseases (e.g., psychotic disorder). Table 1 displays demographic and clinical data by group.
Pain Induction and Assessment
Pain was evoked through a wireless pressure algometer, the Tracker Freedom (JTECH Medical, Lawndale, Salt Lake City, UT, USA), with a surface stimulation area of 1 cm 2 . The pressure algometer was applied manually, but to maximize standardization in this proof-of-concept study, the pressure stimulation level and rate of increase (kg/s) were guided by visual feedback on a computer screen. The algometer was inserted in a screw-piston specifically designed to fix and press the finger nails, allowing for reliable maintenance of stimulation pressure. Stimulation in the fingernails has been shown previously to accurately reflect overall pressure pain sensitivity [21] . To assess the subjective intensity of the evoked pain, a Pain Sensitization in Fibromyalgia 10 cm visual analogue scale (VAS) was completed following each pressure stimulus ("How intense was the pain?"). The anchors of the pain VAS were "painless" and "extremely painful".
Clinical pain was assessed using the McGill Pain Questionnaire (MPQ) [22] in its Spanish version [23] . Three scales were examined: the Sensory and Affective subscales and MPQ Total Score. The internal consistency reliability of the Spanish version for MPQ Total Scores ranges between 0.66 and 0.80 [24] . Patients rated their average pain over the past week.
Assessment of Pain Catastrophizing
All participants completed the Coping Strategies Questionnaire (CSQ), Spanish version, which has been shown to be adequately reliable and valid. For this study, only catastrophizing subscale scores were examined. The internal consistency reliability for the catastrophizing subscale was an a of 0.89 [25] . This measure was examined to rule out potential confounding effects on observed SREP findings of elevated catastrophizing in the FM groups relative to controls.
Procedure
The study was conducted in two sessions that took place on the same day. In the first (screening) session, a clinical psychologist evaluated the inclusion-exclusion criteria, obtained informed consent, assessed the patients' clinical history, and then administered the MPQ and the Spanish version of the CSQ. At the beginning of the second (laboratory) session, participants were instructed regarding the concepts of pain threshold ("when you first start to feel pain") and pain tolerance ("when you reach the maximum stimulation pressure that you can tolerated"). VAS ratings were practiced using a series of six stimuli of different intensities, in the following order: 1.5, 2, 2.9, 1, 2.5, and 0.5 kg/cm 2 . During these training procedures, the second fingernail of the left hand was used. For the remainder of the study, including definitive assessments of pain threshold-tolerance, the third fingernail of the left hand was used. After these practice trials were completed, experimental trials were conducted to determine pain threshold and tolerance values (defined as above), with the stimulus applied using a 1 kg/s rate of pressure increase. Pain pressure used for the SREP protocol was calculated individually for each participant to ensure that a standardized pressure eliciting low to moderate pain was used. To address individual differences in the range between pressure pain threshold and tolerance, SREP pressure stimuli were individualized for each patient using her observed threshold and tolerance values as follows: SREP Intensity ¼ Threshold þ 1.25*(DF/4) [26] ; where DF ¼ Tolerance-Threshold. The pressure level used during the SREP protocol was therefore low and near (slightly above) threshold levels.
In order to attenuate possible peripheral sensitization effects, participants rested quietly after the pain threshold and tolerance trials for 10 minutes before the SREP protocol was carried out. Next, a single series of nine pain stimulation trials was delivered at the individually calibrated pressure level as derived above. Participants were kept unaware of the planned duration or timing of the SREP stimuli in order to minimize expectancy effects. Each pain stimulus lasted five seconds, during which pressure was kept constant. To target afterdischarge phenomena specifically, five seconds after pain withdrawal, the VAS was presented to measure subjective evoked pain intensity. Twenty seconds after VAS assessment, the next trial was started (interstimulus interval of approximately 30 seconds). For analyses, a SREP variable was derived, reflecting the difference in Participants were asked not to consume any analgesic drugs for 24 hours before the study. The study protocol was approved by the Ethics Committee of the University of Jaé n.
Statistical Analysis
No deviation from normality or homogeneity was observed in any variable (P < 0.05 on both Kolmogorov-Smirnov and Levene tests). To analyze the pattern of SREP sensitization, a repeated-measures analysis of variance (ANOVA; 2 Â 9) with one betweensubjects factor (group) and one repeated-measures factor (pain ratings in the nine trials) was conducted. The Greenhouse-Geisser procedure was used to correct the degrees of freedom for violations of sphericity assumptions. Results are reported with the original degrees of freedom and the corrected P values. The used index of SREP sensitization was derived through the difference between the ninth and first VAS ratings (see above). Group comparisons were conducted with Student's t test. Associations between evoked pain and clinical variables were examined in the FM group using Pearson correlations, and differences between these correlation coefficients were tested for significance using Fisher's z statistic. A series of logistic regression analyses were then performed to evaluate the ability of SREP sensitization, threshold, and tolerance to discriminate between the FM and healthy control groups, with sensitivity and specificity indices derived from the resulting actual vs predicted group memberships.
We considered the possibility that catastrophizing differences between the FM and control groups might confound SREP results. Therefore, a hierarchical linear regression analysis was conducted with SREP values as the dependent measure, entering catastrophizing as a predictor in the first step of the analysis, with the group variable (FM vs control) entered in the second step.
While no healthy controls were regularly using medications that might influence evoked pain responses, a subset of the FM group subjects were (see Table 1 ). To rule out potential medication confounds on SREP results, a series of repeated-measures ANOVAs were carried out, examining the pattern of pain ratings across the nine SREP trials as a function of medication use (i.e., 2 x 9 repeated measures). These analyses did not reveal any significant between-subject effects for medication use or any significant trial x medication use interactions on observed pain ratings during the SREP protocol (all P > 0.5). Similar analyses indicated that pain threshold and tolerance were also unaffected by medication status. (Figure 1) . Finally, greater overall perceived intensity of evoked pain was observed in FM patients relative to healthy controls (between-subjects effect of group:
Results
Possible confounding effects of catastrophizing on group SREP differences were considered. Catastrophizing was significantly higher in the FM group than in the control group (see Table 1 ). It was also associated positively with SREP (in FM group; r ¼ 0.44, P ¼ 0.031). However, hierarchical regression analysis revealed that even after controlling for the effects of catastrophizing, the significant differences in SREP between FM and healthy controls remained unchanged (P < 0.001).
Clinical pain ratings for FM patients were 19.88 6 4.67 for the MPQ-Sensory subscale, 3.63 6 2.50 for the MPQ-Affective subscale, and 33.08 6 7.34 for MPQ Total Scores. Significant positive correlations were observed between SREP sensitization and all three MPQ measures of clinical pain (see Table 2 ). Pain tolerance was significantly associated only with MPQAffective ratings, with no significant correlations observed for pain threshold. The correlation between MPQ-Sensory ratings of FM pain and SREP sensitization was significantly larger than comparable correlations for pain threshold (z ¼ À3.04, P < 0.01) and pain tolerance (z ¼ À2.24, P < 0.01). Similarly, the correlation between MPQ Total Scores and SREP sensitization was larger than that observed for pain threshold (z ¼ À2.70, P < 0.01) but was not significantly different from that noted for pain tolerance (z ¼ À1.46, P > 0.1).
Figure 2 displays box and whisker plots for pain threshold, pain tolerance, and SREP sensitization as a function of a group to facilitate comparison of the overlap in between-groups distributions. Overlap in distributions was lower for SREP sensitization than for pain threshold and tolerance measures. Two FM patients (8.3%) had lower SREP sensitization values than the mean value of the healthy controls, while no healthy control participant had a SREP sensitization value greater than the FM mean. Two FM patients (8.3%) had greater threshold values than the mean value in healthy controls, while four healthy participants (16.6%) had a lower threshold than the FM mean. Five FM patients (20.8%) had greater tolerance values than the mean value in healthy controls, while four healthy participants (16.6%) had a lower threshold than the FM mean. Table 3 presents sensitivity and specificity values derived from the logistic regression analysis performed to predict FM vs healthy control group membership using the evoked pain indices. Specificity values in particular were notably higher for SREP than for the traditional pain threshold and pain tolerance measures. In tests of the individual indices, the model for SREP sensitization allowed for superior accuracy of group classification (Beta ¼ À2.90, SE ¼ 0.96, Wald ¼ 9.11, P ¼ 0.003) than models for threshold (Beta ¼ 0.81, SE ¼ 0.32, Wald ¼ 6.45, P ¼ 0.011) or tolerance (Beta ¼ 0.41, SE ¼ 0.16, Wald ¼ 6.06, P ¼ 0.014). Simultaneous entry of pain threshold and pain tolerance did not lead to significant effects for either measure in terms of predicting FM vs healthy control status (P > 0.17). Finally, to determine whether SREP sensitization accounts for significant variance explained beyond that accounted for by traditional measures of pain threshold and tolerance, a sequential logistic regression was conducted, entering pain threshold and tolerance in the first step, and adding SREP sensitization in the second step. This analysis indicated that SREP sensitization added significant group discrimination ability beyond that accounted for by pain threshold and tolerance (Beta ¼ À3.18, SE ¼ 1.08, Wald ¼ 8.67, P ¼ 0.003).
Discussion
Our findings showed a clear and progressive pattern of sensitization to evoked pain stimuli across SREP trials in FM patients that was not observed in healthy controls. Although the current study used a protocol that should not elicit TSP due to its slow rate of repetition, the SREP procedure nonetheless produced a pattern of increasing perceived pain over trials similar to that reported in studies describing elevated TSP to thermal SREP sensitization ¼ Slowly Repeated Evoked Pain protocol. *P 0.05. **P < 0.01.
de la Coba et al.
stimuli in FM patients [11, 27, 28] and augmented sensitization to repeated mechanical stimulation at lower frequencies [2, 3] .
In our study, the intensity of painful stimulation during the SREP protocol was calibrated across individuals by taking into account the pain sensitivity of each participant. This is an important factor as individuals' basal pain sensitivity can strongly affect the degree of sensitization elicited and confound the results of group comparisons [14] . In addition, we used a relatively low-pressure intensity, given evidence that low to moderate pain stimulation at a near-threshold level allows for more accurate detection of associations between pain responses and clinical-physiological parameters compared with more intense pain levels [29] . Crucial methodological differences between our SREP procedure and traditional repeated evoked pain protocols like TSP are 1) a greater interstimulus interval than in TSP studies, 2) the use of a single series of pressure pain stimuli (rather than the more common thermal pain stimuli), and 3) a longer stimulus duration.
Mechanisms underlying the SREP sensitization effect in our study are not clear. Although the SREP protocol produced a clear pattern of increasing perceived pain across repeated stimuli similar to that observed in TSP protocols, the mechanisms underlying SREP sensitization cannot be attributed to traditional temporal summation due to their much lower frequency and longer duration. However, like after-sensations following painful stimuli [14] , SREP sensitization may depend on afterdischarge phenomena in dorsal horn neurons following repetitive fiber-C activation even at rates slower than in traditional TSP protocols. Therefore, SREP sensitization might reflect a lasting facilitation of synaptic transmission in the dorsal horn and related central sensitization processes [19, 30] . More specifically, increases in excitability of dorsal horn neurons that outlast the stimuli and the development of after-discharge phenomena after Pain Sensitization in Fibromyalgia presentation of repetitive pain stimuli [17, 18] might contribute to the SREP sensitization effect.
Beyond possible spinal mechanisms, increased activity during repetitive pain stimulation in brain regions underlying pain processing, associated with the sensory, emotional, and evaluative dimensions of pain [2, 3] , may also have contributed to the SREP sensitization pattern. Unfortunately, neither activity in spinal fibers nor brain activations was assessed in the present study, and thus we cannot specifically relate the results of the SREP protocol to spinal as opposed to brain sensitization mechanisms. The possible influence of local peripheral sensitization in the current SREP results also cannot be ruled out. Finally, we note that controlling statistically for group differences in catastrophizing did not eliminate the observed elevations in SREP in the FM group relative to controls. Therefore, it seems unlikely that elevated SREP is a phenomenon driven primarily by psychosocial factors that are also known to influence pain. Future SREP studies employing neuroimaging techniques and providing direct comparisons of SREP with TSP and other evoked pain measures such as Quantitative Sensory Testing battery [31, 32] would be valuable for elucidating the mechanisms of SREP and determining its relevance to understanding somatosensory abnormalities associated with chronic pain.
In addition to the observed elevations in SREP in the FM group, lower pain threshold and tolerance were observed in FM patients than in healthy controls, reflecting the hyperalgesia that typically characterizes FM [7] [8] [9] . However, when comparing group differences on the three targeted evoked pain indices, the effect size was substantially greater for the SREP sensitization difference compared with those for threshold and tolerance. Furthermore, the SREP measure showed substantially less between-group overlap in its distribution compared with the other two measures. Finally, with respect to discrimination between FM and healthy control groups, the SREP protocol permitted a greater percentage of correct classifications than did either pain threshold or tolerance. The superior discrimination of SREP sensitization was especially evident for specificity; very few healthy control participants were misclassified as FM patients (only two false positives).
Pain threshold was strongly associated with tolerance. However, SREP sensitization was not associated with either pain threshold or tolerance. Similar weak associations between threshold and tolerance measures and results of TSP protocols have been reported in previous studies using heat pain stimuli [33] . Other authors have interpreted such weak associations as indicating different underlying mechanisms between these measures [33] . Also suggesting potentially different mechanisms between these measures are findings that they are differentially influenced by psychological factors and differentially predict clinical pain intensity [17, 31, 34] . As in the prior work above, the low associations of pain threshold and tolerance measures with SREP in the current work may also be interpreted as suggesting differences in underlying mechanisms between these measures. However, due to the methodology used, the current study does not allow determination of the specific mechanisms contributing to SREP responses.
Based on the hypothesis that SREP might be more specifically linked to central sensitization than threshold or tolerance, we expected that clinical pain would show stronger associations with SREP sensitization than with pain threshold-tolerance. Consistent with our hypothesis, ratings of FM pain intensity on the MPQ, both the total score and the sensory subscale specifically, were associated positively with degree of SREP sensitization, while no associations were observed for thresholdtolerance with these clinical outcomes. Observed associations for SREP with these two clinical pain measures were significantly larger than for pain threshold or tolerance. These results are consistent with previous evidence suggesting a weak association between pain threshold-tolerance and clinical pain [34] . Several studies using TSP protocols have also failed to find significant associations between TSP and clinical pain levels in FM patients [14, 16] . However, observed associations between SREP sensitization and FM clinical pain intensity in the current study are consistent with associations observed for after-sensations following serial pain stimuli obtained at 15 and 30 seconds following pain [14, 35] . The findings above suggest that the SREP sensitization measure may be more predictive of levels of clinical FM pain than traditional evoked pain indices. However, studies directly comparing SREP with traditional repeated evoked pain measures like TSP are needed to confirm this hypothesis.
Several limitations of the current work should be noted. First, the test-retest reliability of the SREP protocol remains to be proven. Secondly, the relatively small sample size may have increased the probability of both type I and II errors. Despite the low to moderate statistical power in our study, SREP sensitization seemed to be more clinically relevant than the traditional measures of threshold-tolerance, a least in terms of clinical pain intensity. However, these results need to be replicated in larger samples of participants. Third, we measured pain threshold and tolerance only once, which may have increased measurement variability. Finally, while the SREP protocol may be easier to conduct than typical TSP protocols given the long (30 seconds) interval between stimuli (and patient ratings of those stimuli), the current work used computer-guided pressure stimulation, which would not be available in a typical clinical setting. It would be useful for future studies to examine the clinical feasibility of the SREP protocol using validated automated devices (e.g., Multimodal Automated Sensory Testing) [36] .
In conclusion, a single series of nine slowly repeated low-intensity pain stimuli (SREP) was sufficient to evoke evidence of dynamic pain sensitization in FM. SREP sensitization, in comparison with pain threshold and de la Coba et al.
tolerance measures, was more strongly associated with the sensory dimension of clinical pain. Furthermore, the specificity and effect sizes for the differences between FM patients and healthy participants were greater for SREP sensitization than for either pain threshold or pain tolerance. Further exploration of the SREP protocol is warranted.
